In this case-based CME activity, experts in the field explore the sustained-release formulations of antiglaucoma medications that can improve patient adherence as well as newer MIGS procedures, individualization of therapy, and technology that can optimize outcomes in patients.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/glaucomacme/practice-management/20240521/glaucoma-migs-and-meds-answering-the-call-to-individualize-and-improve-treatment/overview
- Start Date: 2024-05-31 05:00:00
- End Date: 2024-05-31 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- Commercial Support: Source: AbbVie Inc. - Amount: 60565.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest